Hearing loss after discontinuing secondary prophylaxis for cryptococcal meningitis: Relapse or immune reconstitution?

Infection

Volumn 34, Issue 3, 2006, Pages 163-168

  Khanna, N ^a   Nuesch R ^a   Buitrago Tellez, C ^a   Battegay, M ^a   Hirsch, H H ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DEXAMETHASONE; DIDANOSINE; FLUCONAZOLE; FLUCYTOSINE; HYDROXYCHLOROQUINE; LAMIVUDINE; LOPINAVIR; METHYLPREDNISOLONE; NELFINAVIR; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; RITONAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ABDUCENS NERVE PARALYSIS; ADULT; ARTICLE; AUDIOGRAPHY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FUNGAL MENINGITIS; FUNGUS CULTURE; HEARING LOSS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LUMBAR PUNCTURE; MALE; MENINGITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PNEUMOCYSTOSIS; RELAPSE; TREATMENT OUTCOME; VESTIBULOCOCHLEAR NERVE; VIRUS INFECTION; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HEARING LOSS; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; RECURRENCE; TREATMENT OUTCOME;

EID: 33745547420     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-4042-y     Document Type: Article

References (19)

1. Vibhagool A, Sungkanuparph S, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Ingsathit A: Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clin Infect Dis 2003; 36: 1329-1331.
2. Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW, Ledergerber B, Lundgren JD, Furrer H: European HIV Cohorts. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 2002; 137: 239-250.
3. Kaplan JE, Masur H, Holmes KK: Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America 639. MMWR Recomm Rep 2002; 51: 1-52.
4. Hirsch HH, Kaufmann G, Sendi P, Battegay M: Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38: 1159-1166.
5. Woods ML, MacGinley R, Eisen DP, Allworth AM: HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 1998; 12: 1491-1494.
6. Shelburne SA 3rd, Darcourt J, White AC Jr, Greenberg SB, Hamill RJ, Atmar RL, Visnegarwala F: The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049-1052.
7. Jenny-Avital ER, Abadi M: Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002; 35: e128-e133.
8. Trevenzoli M, Cattelan AM, Rea F, Sasset L, Semisa M, Lanzafame M, Meneghetti F, Cadrobbi P: Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J Infect 2002; 45: 173-179.
9. Cattelan AM, Trevenzoli M, Sasset L, Lanzafame M, Marchioro U, Meneghetti F: Multiple cerebral cryptococcomas associated with immune reconstitution in HIV-1 infection. AIDS 2004; 18: 349-351.
10. Boelaert JR, Goddeeris KH, Vanopdenbosch LJ, Casselman JW: Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy. AIDS 2004; 18: 1223-1224.
11. Rambeloarisoa J, Batisse D, Thiebaut JB, Mikol J, Mrejen S, Karmochine M, Kazatchkine MD, Weiss L, Piketty C: Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS. J Infect 2002; 44: 185-188.
12. King MD, Perlino CA, Cinnamon J, Jernigan JA: Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 2002; 13: 724-726.
13. Blanche P, Gombert B, Ginsburg C, Passeron A, Stubei I, Rigolet A, Salmon D, Sicard D: HIV combination therapy: immune restitution causing cryptococcal lymphadenopathy dramatically improved by anti-inflammatory therapy. Scand J Infect Dis 1998; 30: 615-616.
14. Legendre U, Battegay M, Nuttli I, Dalquen P, Nuesch R: Simultaneous occurence of 2 HIV - related immunereconstitution diseases after initiation of highly active antiretroviral therapy. Scand J Infect Dis 2001; 33: 388-389.
15. Breton G, Seilhean D, Cherin P, Herson S, Benveniste O: Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy. Am J Med 2002; 113: 155-157.
16. Cinti SK, Armstrong WS, Kauffman CA: Case report. Recurrence of increased intracranial pressure with antiretroviral therapy in an AIDS patient with cryptococcal meningitis. Mycoses 2001; 44: 497-501.
17. Lanzafame M, Trevenzoli M, Carretta G, Lazzarini L, Vento S, Concia E: Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy. Chest 1999; 116: 848-849.
18. Manfredi R, Pieri F, Pileri SA, Chiodo F: The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review. Mycopathologia 1999; 148: 73-78.
19. Skiest DJ, Hester LJ, Hardy RD: Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature. J Infect 2005; 51: e289-e297.